Cetera Investment Advisers’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.1M | Buy |
|
|||||
|
2025
Q1 | $11.1M | Buy |
|
|||||
|
2024
Q4 | $8.88M | Sell |
|
|||||
|
2024
Q3 | $11.1M | Sell |
|
|||||
|
2024
Q2 | $10.8M | Buy |
|
|||||
|
2024
Q1 | $12.1M | Buy |
|
|||||
|
2023
Q4 | $2.6M | Sell |
|
|||||
|
2023
Q3 | $3.15M | Buy |
|
|||||
|
2023
Q2 | $2.72M | Buy |
|
|||||
|
2023
Q1 | $2.68M | Buy |
|
|||||
|
2022
Q4 | $2.25M | Buy |
|
|||||
|
2022
Q3 | $1.45M | Buy |
|
|||||
|
2022
Q2 | $2.52M | Sell |
|
|||||
|
2022
Q1 | $2.74M | Buy |
|
|||||
|
2021
Q4 | $2.71M | Buy |
|
|||||
|
2021
Q3 | $1.63M | Buy |
|
|||||
|
2021
Q2 | $1.62M | Buy |
|
|||||
|
2021
Q1 | $1.28M | Buy |
|
|||||
|
2020
Q4 | $1.25M | Buy |
|
|||||
|
2020
Q3 | $485K | Sell |
|
|||||
|
2020
Q2 | $549K | Buy |
|
|||||
|
2020
Q1 | $469K | Sell |
|
|||||
|
2019
Q4 | $605K | Sell |
|
|||||
|
2019
Q3 | $557K | Buy |
|
|||||
|
2019
Q2 | $480K | Sell |
|
|||||
|
2019
Q1 | $558K | Sell |
|
|||||
|
2018
Q4 | $520K | Sell |
|
|||||
|
2018
Q3 | $632K | Buy |
|
|||||
|
2018
Q2 | $593K | Buy |
|
|||||
|
2018
Q1 | $566K | Sell |
|
|||||
|
2017
Q4 | $564K | Sell |
|
|||||
|
2017
Q3 | $798K | Sell |
|
|||||
|
2017
Q2 | $1.11M | Buy |
|
|||||
|
2017
Q1 | $1.01M | Sell |
|
|||||
|
2016
Q4 | $1.04M | Buy |
|
|||||
|
2016
Q3 | $686K | Buy |
|
|||||
|
2016
Q2 | $616K | Buy |
|
|||||
|
2016
Q1 | $517K | Buy |
|
|||||
|
2015
Q4 | $407K | Buy |
|